Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
01/21/1999 | WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES |
01/21/1999 | WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
01/21/1999 | WO1999002494A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
01/21/1999 | WO1999002252A1 Improvements in or relating to capsules |
01/21/1999 | WO1999002156A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
01/21/1999 | WO1999002144A1 Anion regulator for ruminants |
01/21/1999 | CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives |
01/21/1999 | CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
01/21/1999 | CA2294757A1 Anion regulator for ruminants |
01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
01/20/1999 | EP0892063A2 Histidine kinase |
01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
01/20/1999 | EP0892057A2 Response regulator |
01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives |
01/20/1999 | EP0891776A1 Simethicone/anhydrous calcium phosphate compositions |
01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use |
01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |
01/20/1999 | EP0891353A1 Inhibitors of farnesyl-protein transferase |
01/20/1999 | EP0891335A1 Inhibitors of farnesyl-protein transferase |
01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
01/20/1999 | EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
01/20/1999 | EP0891186A1 Nasal administration of agents for treatment of delayed onset emesis |
01/20/1999 | EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
01/20/1999 | EP0674624B1 Pyrazoles having crf antagonist activity |
01/20/1999 | EP0630245B1 Protein kinase c inhibitor |
01/20/1999 | CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives |
01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
01/20/1999 | CN1205335A Tricyclic diazepine vasopression antagonists |
01/19/1999 | US5861518 Phthalide compounds and their production process |
01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
01/19/1999 | US5861425 Indole-ethanamines |
01/19/1999 | US5861418 Aminobenzoic acid derivatives |
01/19/1999 | US5861412 Dihydro-isoquinoline compounds and their use as pharmaceuticals |
01/19/1999 | US5861402 1,4-dihydropyridine compounds |
01/19/1999 | US5861401 Treatment of congestive heart failure |
01/19/1999 | US5861394 Use of N-substituted phenothiazines |
01/19/1999 | US5861313 Method of isolating bile duct progenitor cells |
01/19/1999 | US5861048 Dissolving aa alkaline earth metal or iron with a phosphorylated saccharide or one bound to a protein or peptide for use in feeds, fertilizers, foods beverages or tablets |
01/19/1999 | CA2166902C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
01/19/1999 | CA2108455C Pharmaceutical compositions against gastric disorders |
01/19/1999 | CA2037663C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in the obtaining of anti-ulcer drugs, new complexes and chelates resp., of antibiotics with bivalent and/trivalent metals and processes for the obtaining thereof |
01/18/1999 | CA2237050A1 Histidine kinase |
01/18/1999 | CA2237043A1 Response regulator |
01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
01/14/1999 | WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life |
01/14/1999 | WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
01/14/1999 | WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
01/14/1999 | WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists |
01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
01/14/1999 | WO1999001149A1 Health supplement |
01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
01/14/1999 | WO1999001112A1 Multiple unit effervescent dosage form |
01/14/1999 | WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
01/14/1999 | WO1998040097A3 Bovine respiratory and enteric coronavirus as a vaccine |
01/14/1999 | CA2297791A1 Health supplement |
01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
01/14/1999 | CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
01/14/1999 | CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
01/14/1999 | CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
01/14/1999 | CA2236489A1 Novel compounds |
01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
01/13/1999 | EP0889902A1 Antibiotic peptides from bovine milk |
01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
01/13/1999 | EP0889732A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders |
01/13/1999 | EP0889729A1 Linseed drug |
01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
01/13/1999 | EP0757670B1 Benzamide derivatives as vasopressin antagonists |
01/13/1999 | CN1205010A Isoxazolidine derivatives |
01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
01/13/1999 | CN1205006A Substituted tetracyclic tetrahydrofuran derivatives |
01/13/1999 | CN1204526A 'Huweiling' capsule- for protecting stomach |
01/13/1999 | CN1204520A Medicine for treatment of lithiasis |
01/13/1999 | CN1204515A Chinese medicinal preparation for treatment of toothache and method for preparation thereof |
01/13/1999 | CN1204510A Stype using gossypol (and) its derivative as active component and use |
01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |